31.12.69
Novartis AG ( NVS ) Q3 2011 Earnings Call October 25, 2011 8:00 AM ET
Manoeuvrer
Good morning or good afternoon, depending where you're attending from. I'm Stephanie, the Chorus Call manipulator for this conference. Welcome to the Novartis Q3 2011 Results Convention Call and Live Webcast. [Operator Instructions] This call must not be recorded for paper or broadcast. At this time, I would like to turn the convention over to Mr. Joe Jimenez. Please go ahead, sir.
Joseph Jimenez
Show one's gratitude you, and welcome to the third quarter conference call. Joining me on the Novartis end are Jon Symonds, CFO; David Epstein, the Prime of the Pharma division; Kevin Buehler, Take charge of of Alcon; Jeff George, Head of Sandoz; and Andrin Oswald, Fully of Vaccines and Diagnostics.
Before we begin, I'd like to ask Susanne Schaffert to decipher the Safe Harbor statement.
Susanne Schaffert
The message presented in this conference call contains forward-looking statements that take in known and unknown risks, uncertainties and other factors. These may creator actual results to be materially different from any coming results, performance or achievements expressed or implied by such statements. Please refer to the fellowship's Form 20-F on file with the Securities and Unpleasantness Commission for a description of some of these factors.
Source: Seeking Alpha